中国临床药理学与治疗学 ›› 2026, Vol. 31 ›› Issue (5): 639-648.doi: 10.12092/j.issn.1009-2501.2026.05.008
王夏颖1(
), 蒋虎刚1,2,3, 任春贞1,2, 马静1, 刘佳坤1, 刘凯1,2,3, 李应东1,2,3, 赵信科1,2,3,*(
)
收稿日期:2025-06-29
修回日期:2025-09-03
出版日期:2026-05-26
发布日期:2026-06-02
通讯作者:
赵信科
E-mail:1686610858@qq.com;zxkd412@163.com
作者简介:王夏颖,女,在读硕士研究生,研究方向:中西医结合防治心血管疾病。E-mail:基金资助:
Xiaying WANG1(
), Hugang JIANG1,2,3, Chunzhen REN1,2, Jing MA1, Jiakun LIU1, Kai LIU1,2,3, Yingdong LI1,2,3, Xinke ZHAO1,2,3,*(
)
Received:2025-06-29
Revised:2025-09-03
Online:2026-05-26
Published:2026-06-02
Contact:
Xinke ZHAO
E-mail:1686610858@qq.com;zxkd412@163.com
摘要:
放射性心脏病(radiation-induced heart disease,RIHD)是胸部肿瘤放射治疗中最常见、最严重的并发症。心脏组织受到放射线的辐射后,出现心肌炎症、纤维化和血管内皮损伤等,进而引发心脏功能障碍。医疗水平的不断提升,大幅度延长了肿瘤患者的生存期,但是RIHD却严重影响了患者的生存质量。为了深入探究其病理机制,构建可靠的RIHD细胞模型是研究其分子机制和评估治疗效果的重要实验基础。本文总结了近年来国内外RIHD细胞模型在相关研究中的应用及研究进展,以期为RIHD的研究提供可靠的理论依据。
中图分类号:
王夏颖, 蒋虎刚, 任春贞, 马静, 刘佳坤, 刘凯, 李应东, 赵信科. 放射性心脏病体外模型的构建策略与应用挑战[J]. 中国临床药理学与治疗学, 2026, 31(5): 639-648.
Xiaying WANG, Hugang JIANG, Chunzhen REN, Jing MA, Jiakun LIU, Kai LIU, Yingdong LI, Xinke ZHAO. Construction strategy and application of an in vitro model of radioactive cardiac injury[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2026, 31(5): 639-648.
| Detection target | Molecular biomarkers/functional indicators | Detection techniques | References |
| Oxidative stress | ROS levels, SOD activity, MDA content | DCFH-DA fluorescent probe | [ |
| Apoptosis/vecrosis | Caspase-3 activity, Bax/Bcl-2 ratio, LDH release | Annexin V/PI double staining, Western Blot, LDH assay kit | [ |
| Cell viability and proliferation | Cell survival rate, proliferation curve staining | CCK-8/MTT assay, EdU staining | [ |
| DNA damage | γ-H2AX foci, ATM/ATR phosphorylation | Immunofluorescence, Western Blot | [ |
| Fibrosis | TGF-β1, α-SMA, CollagenⅠ/Ⅲ | ELISA, Immunofluorescence, Sirius red staining | [ |
| Mitochondrial dysfunction | ATP content, membrane potential (ΔΨm), mtROS | JC-1 probe (Flow cytometry), Seahorse XF Analyzer (oxygen consumption rate) | [ |
| Inflammatory response | IL-6, TNF-α, IL-1β | (Luminex), RT-qPCR Multiplex liquid chip (Luminex), RT-qPCR (mRNA level) | [ |
表 1
Table 1 Core molecular biomarkers and detection techniques
| Detection target | Molecular biomarkers/functional indicators | Detection techniques | References |
| Oxidative stress | ROS levels, SOD activity, MDA content | DCFH-DA fluorescent probe | [ |
| Apoptosis/vecrosis | Caspase-3 activity, Bax/Bcl-2 ratio, LDH release | Annexin V/PI double staining, Western Blot, LDH assay kit | [ |
| Cell viability and proliferation | Cell survival rate, proliferation curve staining | CCK-8/MTT assay, EdU staining | [ |
| DNA damage | γ-H2AX foci, ATM/ATR phosphorylation | Immunofluorescence, Western Blot | [ |
| Fibrosis | TGF-β1, α-SMA, CollagenⅠ/Ⅲ | ELISA, Immunofluorescence, Sirius red staining | [ |
| Mitochondrial dysfunction | ATP content, membrane potential (ΔΨm), mtROS | JC-1 probe (Flow cytometry), Seahorse XF Analyzer (oxygen consumption rate) | [ |
| Inflammatory response | IL-6, TNF-α, IL-1β | (Luminex), RT-qPCR Multiplex liquid chip (Luminex), RT-qPCR (mRNA level) | [ |
| Drugs | Cell model | Dosage | Time | Method | Mechanisms | Therapeutic effects | References |
| Angelica-hedysarum polysaccharide | H9C2 irradiated with 2 Gy X-ray, detected at 24 h | 400 mg/L | 24 h | DEME | Rho/Rock↓ | Anti-fibrotic, inhibits myocardial remodeling | [ |
| Astragalus injection | CFs irradiated with 2 Gy X-ray, detected at 48 h | 10 μg/mL 20 μg/mL | 48 h | DEME | TGF-β1↓ Col-Ⅰ↓ | Reduces ROS, inhibits ER stress and fibrosis | [ |
| Shenmai injection | H9C2 irradiated with 20 Gy X-ray, detected at 72 h | 1 μL/mL 5 μL/mL | 72 h | DEME | ROS↓ | Inhibits myocardial fibrosis and macrophage infiltration | [ |
| Salidroside | H9C2 irradiated with 6 Gy X-ray, detected at 48 h | 0.50 mmol/L | 24 h | DEME | Bcl-2/Bax↑ | Anti-inflammatory; mitigates cardiac injury | [ |
| Angelica- hedysarum ultrafiltrate | H9C2 irradiated with 6 Gy X-ray, detected at 24 h | 3,6,9 mg/mL | 48 h | DEME | LDH↓, Bax, SOD↑ | Antioxidant; reduces myocardial cell damage | [ |
| Resveratrol | H9C2 irradiated with 4 Gy X-ray, detected at 48 h | 50 μmol/L | 24 h | DEME | TGF-β1↓ | Alleviates oxidative stress and inflammation | [ |
| Astragalus polysaccharide | H9C2 irradiated with 4 Gy X-ray, detected at 24 h | 400 μg/mL | 48 h | DEME | PI3K/Akt/ mTOR↑ | Improves radiation-induced autophagic flux; reduces apoptosis and atrophy | [ |
| Astragalosides | CFs irradiated with 1 Gy X-ray, detected at 48 h | 20 mg/mL | 48 h | DEME | TGF-β1 Col-Ⅰ↓ | Reduces ROS; alleviates radiation-induced fibrosis | [ |
Astragaloside IV | HUVECs irradiated with 4 Gy X-ray, detected at 24 h | 100 μg/mL | 12 h | DEME | SOD↑ | Anti-inflammatory; mitigates cardiac injury | [ |
表 2
Table 2 Effect of TCM and its active ingredients on RIHD progression
| Drugs | Cell model | Dosage | Time | Method | Mechanisms | Therapeutic effects | References |
| Angelica-hedysarum polysaccharide | H9C2 irradiated with 2 Gy X-ray, detected at 24 h | 400 mg/L | 24 h | DEME | Rho/Rock↓ | Anti-fibrotic, inhibits myocardial remodeling | [ |
| Astragalus injection | CFs irradiated with 2 Gy X-ray, detected at 48 h | 10 μg/mL 20 μg/mL | 48 h | DEME | TGF-β1↓ Col-Ⅰ↓ | Reduces ROS, inhibits ER stress and fibrosis | [ |
| Shenmai injection | H9C2 irradiated with 20 Gy X-ray, detected at 72 h | 1 μL/mL 5 μL/mL | 72 h | DEME | ROS↓ | Inhibits myocardial fibrosis and macrophage infiltration | [ |
| Salidroside | H9C2 irradiated with 6 Gy X-ray, detected at 48 h | 0.50 mmol/L | 24 h | DEME | Bcl-2/Bax↑ | Anti-inflammatory; mitigates cardiac injury | [ |
| Angelica- hedysarum ultrafiltrate | H9C2 irradiated with 6 Gy X-ray, detected at 24 h | 3,6,9 mg/mL | 48 h | DEME | LDH↓, Bax, SOD↑ | Antioxidant; reduces myocardial cell damage | [ |
| Resveratrol | H9C2 irradiated with 4 Gy X-ray, detected at 48 h | 50 μmol/L | 24 h | DEME | TGF-β1↓ | Alleviates oxidative stress and inflammation | [ |
| Astragalus polysaccharide | H9C2 irradiated with 4 Gy X-ray, detected at 24 h | 400 μg/mL | 48 h | DEME | PI3K/Akt/ mTOR↑ | Improves radiation-induced autophagic flux; reduces apoptosis and atrophy | [ |
| Astragalosides | CFs irradiated with 1 Gy X-ray, detected at 48 h | 20 mg/mL | 48 h | DEME | TGF-β1 Col-Ⅰ↓ | Reduces ROS; alleviates radiation-induced fibrosis | [ |
Astragaloside IV | HUVECs irradiated with 4 Gy X-ray, detected at 24 h | 100 μg/mL | 12 h | DEME | SOD↑ | Anti-inflammatory; mitigates cardiac injury | [ |
| 1 |
Chen J, Li M, Yu Y, et al. Prevention of ventricular arrhythmia complicating acute myocardial infarction by local cardiac denervation[J]. Int J Cardiol, 2015, 184, 667- 673.
doi: 10.1016/j.ijcard.2015.03.057 |
| 2 |
Darby SC, Cutter DJ, Boerma M, et al. Radiation-related heart disease: current knowledge and future prospects[J]. Int J Radiat Oncol Biol Phys, 2010, 76 (3): 656- 665.
doi: 10.1016/j.ijrobp.2009.09.064 |
| 3 |
Pan L, Lei D, Wang W, et al. Heart dose linked with cardiac events and overall survival in lung cancer radiotherapy: A meta-analysis[J]. Medicine (Baltimore), 2020, 99 (38): e21964.
doi: 10.1097/md.0000000000021964 |
| 4 |
胡舜英, 邱乐, 段海峰, 等. 肝细胞生长因子在大鼠心肌细胞放射损伤中的抗凋亡作用[J]. 解放军医学杂志, 2007, 32 (5): 482- 484.
doi: 10.3321/j.issn:0577-7402.2007.05.023 |
| 5 | 蒋虎刚. 基于益气活血理论探讨当归红芪多糖干预放射性心肌损伤的作用及分子机制 [D]. 兰州: 兰州大学, 2019. |
| 6 |
邢喜平, 任春贞, 蒋虎刚, 等. 基于Rho/Rock通路探讨当归红芪多糖对辐射诱导大鼠H9C2心肌细胞的作用机制[J]. 辽宁中医杂志, 2021, 48 (7): 228- 231,262.
doi: 10.13192/j.issn.1000-1719.2021.07.061 |
| 7 | 顾静. X射线诱导心肌成纤维细胞促纤维化损伤及黄芪注射液对其干预的实验研究 [D]. 西安: 陕西中医药大学, 2014. |
| 8 | 郭欢. miR-21 对辐射后大鼠心脏成纤维细胞基因表达谱的影响及miR-21/GDF15促放射性纤维化机制研究 [D]. 兰州: 兰州大学, 2021. |
| 9 |
Zeng ZM, Du HY, Xiong L, et al. BRCA1 protects cardiac microvascular endothelial cells against irradiation by regulating p21-mediated cell cycle arrest[J]. Life Sci, 2020, 244, 117342.
doi: 10.1016/j.lfs.2020.117342 |
| 10 |
Yi J, Yue L, Zhang Y, et al. PTPMT1 protects cardiomyocytes from necroptosis induced by γ-ray irradiation through alleviating mitochondria injury[J]. Am J Physiol Cell Physiol, 2023, 324 (6): C1320- C1331.
doi: 10.1152/ajpcell.00466.2022 |
| 11 |
Zeng Z, Xu P, He Y, et al. Acetylation of atp5f1c mediates cardiomyocyte senescence via metabolic dysfunction in radiation-induced heart damage[J]. Oxid Med Cell Longev, 2022, 2022, 4155565.
doi: 10.1155/2022/4155565 |
| 12 | 刘侃玲. 自噬在PM2.5致冠状动脉微血管内皮细胞损伤中的作用及其机制 [D]. 广州: 南方医科大学, 2016. |
| 13 | 徐祎琳. 白藜芦醇通过上调SIRT1表达介导对放射性心肌损伤的保护作用 [D]. 兰州: 兰州大学, 2022. |
| 14 | 赵信科. 基于TNF-α/CTRP9/p42/44MAPK信号通路探讨当归红芪超滤物干预重离子束致心肌细胞损伤的氧化应激机制 [M]. 北京: 人民卫生出版社, 2022. |
| 15 |
Cui WW, Ye C, Wang KX, et al. Momordica charantia-derived extracellular vesicles-like nanovesicles protect cardiomyocytes against radiation injury via attenuating DNA damage and mitochondria dysfunction[J]. Front Cardiovasc Med, 2022, 9, 864188.
doi: 10.3389/fcvm.2022.864188 |
| 16 | 张文静. 丹参酮ⅡA磺酸钠对放射性心肌细胞损伤的保护作用及机制研究 [D]. 合肥: 安徽医科大学, 2016. |
| 17 | Edwards S, Adams J, Tchernikov A, et al. Low-dose X-ray radiation induces an adaptive response: A potential countermeasure to galactic cosmic radiation exposure[J]. Exp Physiol, 2024, 109 (8): 1123- 1132. |
| 18 |
Gu A, Jie Y, Sun L, et al. RhNRG-1β protects the myocardium against irradiation-induced damage via the ErbB2-ERK-SIRT1 signaling pathway[J]. PLoS One, 2015, 10 (9): e0137337.
doi: 10.1371/journal.pone.0137337 |
| 19 |
Wang G, Ma L, Wang B, et al. Tanshinone IIA accomplished protection against radiation-induced cardiomyocyte injury by regulating the p38/p53 pathway[J]. Mediators Inflamm, 2022, 2022, 1478181.
doi: 10.1155/2022/1478181 |
| 20 | 贾成文. 当归红芪超滤物对miRNA-21-5P靶向调控TGF-β1/Smad3信号通路介导放射性心肌纤维化的干预效应 [D]. 兰州: 甘肃中医药大学, 2023. |
| 21 | 孔姗姗, 汪鸣, 蒋虎刚, 等. 当归红芪超滤物对放射性H9C2细胞损伤TNF-α/CTRP9信号通路相关因子表达的影响[J]. 中国中医药信息杂志, 2021, 28 (5): 50- 54. |
| 22 |
Li YL, Wang G, Wang BW, et al. The potential treatment of N-acetylcysteine as an antioxidant in the radiation-induced heart disease[J]. Cardiovasc Diagn Ther, 2024, 14 (4): 509- 524.
doi: 10.21037/cdt-24-19 |
| 23 | Gáspár R, Diószegi P, Nógrádi-Halmi D, et al. The proteoglycans biglycan and decorin protect cardiac cells against irradiation-induced cell death by inhibiting apoptosis[J]. Cells, 2024, 13 (10): 1485. |
| 24 |
Kiscsatári L, Varga Z, Schally AV, et al. Protection of neonatal rat cardiac myocytes against radiation-induced damage with agonists of growth hormone-releasing hormone[J]. Pharmacol Res, 2016, 111, 859- 866.
doi: 10.1016/j.phrs.2016.07.036 |
| 25 |
Li L, Nie X, Zhang P, et al. Dexrazoxane ameliorates radiation-induced heart disease in a rat model[J]. Aging (Albany NY), 2021, 13 (3): 3699- 3711.
doi: 10.18632/aging.202332 |
| 26 |
Chang J, Ma C, Guo H, et al. Ultrafiltration extract of radix angelica sinensis and radix hedysari attenuates risk of low-dose x-ray radiation-induced myocardial fibrosis in vitro[J]. Evid Based Complement Alternat Med, 2021, 2021, 5580828.
doi: 10.1155/2021/5580828 |
| 27 |
Xu P, Yi Y, Xiong L, et al. Oncostatin m/oncostatin m receptor signal induces radiation-induced heart fibrosis by regulating SMAD4 in fibroblast[J]. Int J Radiat Oncol Biol Phys, 2024, 118 (1): 203- 217.
doi: 10.1016/j.ijrobp.2023.07.033 |
| 28 |
Wang KX, Ye C, Yang X, et al. New insights into the understanding of mechanisms of radiation-induced heart disease[J]. Curr Treat Options Oncol, 2023, 24 (1): 12- 29.
doi: 10.1007/s11864-022-01041-4 |
| 29 | Wu B, Zhao S, Zhang J, et al. PD-1 inhibitor aggravate irradiation-induced myocardial fibrosis by regulating tgf-β1/Smads signaling pathway via GSDMD-mediated pyroptosis[J]. Inflammation, 2024, 47 (6): 2145- 2158. |
| 30 | Sun T, Liu H, Cheng Y, et al. 2, 3, 5, 4'-Tetrahydroxystilbene-2-O-β-d-glucoside eliminates ischemia/reperfusion injury-induced H9c2 cardiomyocytes apoptosis involving in Bcl-2, Bax, caspase-3, and Akt activation[J]. J Cell Biochem, 2019, 120 (7): 10972- 10977. |
| 31 |
Hu C, Zhang X, Wei W, et al. Matrine attenuates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via maintaining AMPKα/UCP2 pathway[J]. Acta Pharm Sin B, 2019, 9 (4): 690- 701.
doi: 10.1016/j.apsb.2019.03.003 |
| 32 |
Elrod JW, Wong R, Mishra S, et al. Cyclophilin D controls mitochondrial pore-dependent Ca(2+) exchange, metabolic flexibility, and propensity for heart failure in mice[J]. J Clin Invest, 2010, 120 (10): 3680- 3687.
doi: 10.1172/JCI43171 |
| 33 |
Zamorano JL, Lancellotti P, Rodriguez Muñoz D, et al. 2016 ESC position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC committee for practice guidelines: the task force for cancer treatments and cardiovascular toxicity of the european society of cardiology (ESC)[J]. Eur Heart J, 2016, 37 (36): 2768- 2801.
doi: 10.1093/eurheartj/ehw211 |
| 34 |
Moussad EE, Brigstock DR. Connective tissue growth factor: what's in a name?[J]. Mol Genet Metab, 2000, 71 (1-2): 276- 292.
doi: 10.1006/mgme.2000.3059 |
| 35 |
Pan X, Chen Z, Huang R, et al. Transforming growth factor β1 induces the expression of collagen type I by DNA methylation in cardiac fibroblasts[J]. PLoS One, 2013, 8 (4): e60335.
doi: 10.1371/journal.pone.0060335 |
| 36 |
Collins T, Cybulsky MI. NF-kappaB: pivotal mediator or innocent bystander in atherogenesis?[J]. J Clin Invest, 2001, 107 (3): 255- 264.
doi: 10.1172/JCI10373 |
| 37 |
Lebranchu Y, Bridoux F, Büchler M, et al. Immunoprophylaxis with basiliximab compared with antithymocyte globulin in renal transplant patients receiving MMF-containing triple therapy[J]. Am J Transplant, 2002, 2 (1): 48- 56.
doi: 10.1034/j.1600-6143.2002.020109.x |
| 38 | Caligiuri A, Gitto S, Lori G, et al. Oncostatin M: from intracellular signaling to therapeutic targets in liver cancer[J]. Cancers (Basel), 2022, 14 (17): 4162. |
| 39 |
Nakajima H, Nakajima HO, Salcher O, et al. Atrial but not ventricular fibrosis in mice expressing a mutant transforming growth factor-beta (1) transgene in the heart[J]. Circ Res, 2000, 86 (5): 571- 579.
doi: 10.1161/01.RES.86.5.571 |
| 40 |
Chia ZJ, Cao YN, Little PJ, et al. Transforming growth factor-β receptors: versatile mechanisms of ligand activation[J]. Acta Pharmacol Sin, 2024, 45 (7): 1337- 1348.
doi: 10.1038/s41401-024-01235-6 |
| 41 |
Mathias D, Mitchel RE, Barclay M, et al. Low-dose irradiation affects expression of inflammatory markers in the heart of ApoE -/- mice[J]. PLoS One, 2015, 10 (3): e0119661.
doi: 10.1371/journal.pone.0119661 |
| 42 |
Baselet B, Sonveaux P, Baatout S. Pathological effects of ionizing radiation: endothelial activation and dysfunction[J]. Cell Mol Life Sci, 2019, 76 (4): 699- 728.
doi: 10.1007/s00018-018-2956-z |
| 43 |
Preidl RHM, Möbius P, Weber M. Correction to: Long-term endothelial dysfunction in irradiated vessels: an immunohistochemical analysis[J]. Strahlenther Onkol, 2020, 196 (5): 485.
doi: 10.1007/s00066-019-01564-0 |
| 44 |
Patties I, Haagen J, Dörr W. Late inflammatory and thrombotic changes in irradiated hearts of C57BL/6 wild-type and atherosclerosis-prone ApoE-deficient mice[J]. Strahlenther Onkol, 2015, 191 (2): 172- 179.
doi: 10.1007/s00066-014-0745-7 |
| 45 |
Halle M, Gabrielsen A, Paulsson-Berne G, et al. Sustained inflammation due to nuclear factor-kappa B activation in irradiated human arteries[J]. J Am Coll Cardiol, 2010, 55 (12): 1227- 1236.
doi: 10.1016/j.jacc.2009.10.047 |
| 46 | 杜海洋. BRCA1/p21基因敲除对小鼠放射性心脏损伤的影响 [D]. 北京: 北京协和医学院, 2020. |
| 47 |
Liu T, Zhang L, Joo D, et al. NF-κB signaling in inflammation[J]. Signal Transduct Target Ther, 2017, 2, 17023.
doi: 10.1038/sigtrans.2017.23 |
| 48 | 闫冰川, 苏旭春, 孔嘉欣, 等. 参芪扶正注射液预防放射性心脏损伤临床观察[J]. 湖南中医杂志, 2012, 28 (4): 4- 6. |
| 49 | 钱永红. 生脉注射液防治放射性心脏损伤疗效观察[J]. 北方药学, 2014, 11 (7): 51- 52. |
| 50 |
Ziegler V, Henninger C, Simiantonakis I, et al. Rho inhibition by lovastatin affects apoptosis and DSB repair of primary human lung cells in vitro and lung tissue in vivo following fractionated irradiation[J]. Cell Death Dis, 2017, 8 (8): e2978.
doi: 10.1038/cddis.2017.372 |
| 51 |
Talebpour Amiri F, Hamzeh M, Naeimi RA. Radioprotective effect of atorvastatin against ionizing radiation-induced nephrotoxicity in mice[J]. Int J Radiat Biol, 2018, 94 (2): 106- 113.
doi: 10.1080/09553002.2018.1420926 |
| 52 |
Kang J, Kim YC, Park JJ, et al. Increased epicardial adipose tissue thickness is a predictor of new-onset diabetes mellitus in patients with coronary artery disease treated with high-intensity statins[J]. Cardiovasc Diabetol, 2018, 17 (1): 10.
doi: 10.1186/s12933-017-0650-3 |
| 53 |
Krum H, Schlaich MP, Sobotka PA, et al. Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study[J]. Lancet, 2014, 383 (9917): 622- 629.
doi: 10.1016/S0140-6736(13)62192-3 |
| 54 |
Chaldakov GN. Colchicine, a microtubule-disassembling drug, in the therapy of cardiovascular diseases[J]. Cell Biol Int, 2018, 42 (8): 1079- 1084.
doi: 10.1002/cbin.10988 |
| 55 | 李鹏. RIHD小鼠模型的建立与评价及天麻素对其影响的研究 [D]. 遵义: 遵义医科大学, 2020. |
| 56 | 沈伟生, 夏德洪, 高春恒, 等. 参松养心胶囊加红景天干预放射性心脏损伤的临床研究[J]. 南京中医药大学学报, 2016, 32 (5): 431- 434. |
| 57 | 杨旭光, 田迎霞, 沈蓉, 等. 放射性心脏损伤的机制及治疗研究进展[J]. 兰州大学学报(医学版), 2022, 48 (2): 81- 86. |
| 58 | 冯璟, 于远望. 当归补血汤对辐射损伤小鼠的防护作用[J]. 中国比较医学杂志, 2015, 25 (10): 55- 58. |
| 59 | 范习刚, 吴飞, 杨桄权, 等. 黄芪生脉饮联合阿司匹林对胸部肿瘤放疗后放射性心脏损伤的防治作用研究[J]. 世界中西医结合杂志, 2022, 17 (1): 111- 115. |
| 60 |
Li H, Cao L, Yi PQ, et al. Pituitary adenylate cyclase-activating polypeptide ameliorates radiation-induced cardiac injury[J]. Am J Transl Res, 2019, 11 (10): 6585- 6599.
doi: 10.1016/j.ijrobp.2019.06.1051 |
| 61 | 畅艳娜, 李应东, 王雪梅, 等. 当归红芪超滤物抗辐射致心肌细胞损伤的作用及机制[J]. 世界中西医结合杂志, 2014, 9 (5): 487- 491. |
| 62 | 徐梦游. 参麦注射液在放射性心脏损伤中的保护作用研究 [D]. 南京: 南京中医药大学, 2021. |
| 63 | Ping Z, Peng Y, Lang H, et al. Oxidative stress in radiation-induced cardiotoxicity[J]. Oxid Med Cell Longev, 2020, 2020, 3579143. |
| 64 | 顾静. 中医药对放射性心脏纤维化损伤的尝试性干预研究 [C]. 中国生理学会张锡钧基金第十五届全国青年优秀生理学学术论文交流及评奖会议; 中国生理学会第十三届全国青年生理学工作者学术会议, 2019: 2. |
| 65 |
辛二旦, 张育贵, 边甜甜, 等. 黄芪甲苷对心血管疾病的作用机制研究状况[J]. 中国临床药理学杂志, 2024, 40 (17): 2580- 2585.
doi: 10.13699/j.cnki.1001-6821.2024.17.026 |
| 66 |
Wu X, Zhi X, Liu K, et al. Prevention and control of cardiac arrhythmic by using therapeutic foods: a review[J]. J Cardiovasc Electrophysiol, 2024, 35 (11): 1892- 1901.
doi: 10.1111/jce.16428 |
| [1] | 曹志文, 颜桂军. 子宫内膜上皮细胞类器官在生殖领域的研究进展[J]. 中国临床药理学与治疗学, 2024, 29(5): 576-582. |
| [2] | 吴丹, 刁勇, 徐先祥. 高尿酸细胞模型研究进展[J]. 中国临床药理学与治疗学, 2021, 26(2): 236-240. |
| [3] | 翟宇, 杨劲. 饮食维生素K对华法林抗凝稳定性的影响[J]. 中国临床药理学与治疗学, 2020, 25(6): 709-715. |
| [4] | 刘妍, 刘嘉莉, 贾元威, 周芳, 王广基, 张经纬. 抗肿瘤药物的瘤内转运评价研究进展[J]. 中国临床药理学与治疗学, 2020, 25(10): 1151-1159. |
| [5] | 鲁 萌,周 芳,刘嘉莉,贾元威,倪 苹,王广基,张经纬. 三维细胞模型在抗肿瘤药物早期药代动力学筛选中的应用进展[J]. 中国临床药理学与治疗学, 2017, 22(3): 342-349. |
| [6] | 齐 潇,肖 婉,陈 卉,涂 娇,倪 平,许林勇. 标准化数据采集平台构建及在临床试验数据质量控制的应用[J]. 中国临床药理学与治疗学, 2016, 21(12): 1384-1388. |
| [7] | 赵吟, 李钦, 张信岳. 基于RBL-2H3细胞模型的I型过敏反应和类过敏反应研究[J]. 中国临床药理学与治疗学, 2010, 15(11): 1310-1314. |
| [8] | 周昕. 药物吸收体外研究方法的概述[J]. 中国临床药理学与治疗学, 2006, 11(4): 379-384. |
| [9] | 周星辉, 王丙力, 谭焕然. 大鼠肝实质细胞原代培养模型的研究及其功能鉴定[J]. 中国临床药理学与治疗学, 2005, 10(7): 743-746. |
| [10] | 李婷, 张小东, 宋聿文, 刘建文. 一种用微孔板筛选alpha-葡萄糖苷酶抑制剂的方法[J]. 中国临床药理学与治疗学, 2005, 10(10): 1128-1134. |
| [11] | 程玉芳, 徐江平. 细胞黏附分子与药物研制[J]. 中国临床药理学与治疗学, 2005, 10(1): 5-8. |
| [12] | 张雅丽, 肖梅芳, 谭焕然. 大鼠胰岛细胞原代培养模型的研究[J]. 中国临床药理学与治疗学, 2004, 9(11): 1231-1235. |
| 阅读次数 | ||||||
|
全文 |
|
|||||
|
摘要 |
|
|||||